While DNMT3B mutations are rarely detected in hematopoietic malignancies (27–29), DNMT3A mutations are very common in patients with clonal hematopoiesis and/or myeloid malignancies, and also cause the DNMT3A overgrowth syndrome (DOS). Here, DNMT3A is linked to myeloid neoplasm.